Quanta Services, Inc. (NYSE: PWR) announced today that company management will participate in the Wolfe Research Utilities, Midstream & Clean Energy Conference 2024. Duke Austin, Chief Executive...

Phase 2 company-sponsored and IST neoadjuvant uveal melanoma (UM) clinical data update in 49 evaluable patients, demonstrates ~49% of patients with >30% tumor shrinkage by product of diameters,...

On September 14, 2024, BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadherin) in a Phase I...

Pitching Challenge to Reward Companies with United States Pilot and Funding Opportunities DALLAS, Sept. 23, 2024 /PRNewswire/ -- North Texas Innovation Alliance (NTXIA), a 501(c)3 regional...

The 2024 International Low-altitude Economy Product Release and Investment Conference was successfully held in Chengdu, a city with passion, where attracted the global attention of low-altitude...